Showing 1 to 12 of 40 results
Eli Lilly CEO Calls UK "Worst in Europe" for Drug Prices, Threatening Investment
Eli Lilly's CEO, Dave Ricks, criticized the UK's drug pricing regime as the "worst in Europe," citing it as a reason for the pharmaceutical industry's withdrawal of nearly £2 billion in planned investments.
Eli Lilly CEO Calls UK "Worst in Europe" for Drug Prices, Threatening Investment
Eli Lilly's CEO, Dave Ricks, criticized the UK's drug pricing regime as the "worst in Europe," citing it as a reason for the pharmaceutical industry's withdrawal of nearly £2 billion in planned investments.
Progress
56% Bias Score
England's Weight Loss Jab Rollout Faces Challenges: Access Issues and Funding Shortfalls
A new report reveals that the NHS rollout of weight-loss injections in England is facing significant challenges, with thousands of eligible patients unable to access the treatment due to insufficient funding and uneven distribution across different regions.
England's Weight Loss Jab Rollout Faces Challenges: Access Issues and Funding Shortfalls
A new report reveals that the NHS rollout of weight-loss injections in England is facing significant challenges, with thousands of eligible patients unable to access the treatment due to insufficient funding and uneven distribution across different regions.
Progress
40% Bias Score
Weight-Loss Injections Reshape UK Wedding Dress Industry
The surge in popularity of weight-loss injections like Ozempic and Wegovy in the UK is causing significant challenges for bridal businesses, as brides' rapid weight loss necessitates expensive and time-consuming last-minute alterations.
Weight-Loss Injections Reshape UK Wedding Dress Industry
The surge in popularity of weight-loss injections like Ozempic and Wegovy in the UK is causing significant challenges for bridal businesses, as brides' rapid weight loss necessitates expensive and time-consuming last-minute alterations.
Progress
16% Bias Score
Mounjaro UK Price Soars 170% Amid US Cost-Cutting Push
Eli Lilly announced a 170% price hike for its weight-loss drug Mounjaro in the UK, increasing the highest dose to £330 per month, to align UK pricing with other European markets and lower US costs, though the NHS remains unaffected.
Mounjaro UK Price Soars 170% Amid US Cost-Cutting Push
Eli Lilly announced a 170% price hike for its weight-loss drug Mounjaro in the UK, increasing the highest dose to £330 per month, to align UK pricing with other European markets and lower US costs, though the NHS remains unaffected.
Progress
52% Bias Score
Mounjaro Price Hike in UK Reaches 170% Amidst Trump's Drug Pricing Pressure
Eli Lilly will increase the price of its weight-loss injection Mounjaro in the UK by up to 170% from September, aligning it with other European markets despite the NHS not paying the increased price; this follows pressure from Donald Trump to lower US drug prices by reducing prices in Europe.
Mounjaro Price Hike in UK Reaches 170% Amidst Trump's Drug Pricing Pressure
Eli Lilly will increase the price of its weight-loss injection Mounjaro in the UK by up to 170% from September, aligning it with other European markets despite the NHS not paying the increased price; this follows pressure from Donald Trump to lower US drug prices by reducing prices in Europe.
Progress
48% Bias Score
Forged Prescriptions for Weight-Loss Drugs Rise in Northern Germany
Criminals in northern Germany are forging prescriptions for weight-loss medications like Ozempic and Wegovy, exploiting high demand fueled by social media trends and celebrity endorsements; the introduction of e-prescriptions is reducing but not eliminating the problem, leaving pharmacies financiall...
Forged Prescriptions for Weight-Loss Drugs Rise in Northern Germany
Criminals in northern Germany are forging prescriptions for weight-loss medications like Ozempic and Wegovy, exploiting high demand fueled by social media trends and celebrity endorsements; the introduction of e-prescriptions is reducing but not eliminating the problem, leaving pharmacies financiall...
Progress
36% Bias Score
Insufficient NHS Funding Limits Mounjaro Access for Obesity
New research reveals that limited NHS funding will restrict access to the Mounjaro weight-loss jab for obesity to as few as one in five eligible people in England, despite 220,000 people being eligible over three years.
Insufficient NHS Funding Limits Mounjaro Access for Obesity
New research reveals that limited NHS funding will restrict access to the Mounjaro weight-loss jab for obesity to as few as one in five eligible people in England, despite 220,000 people being eligible over three years.
Progress
44% Bias Score
Mounjaro Price Hike Jeopardizes Mental Health Benefits for Weight Loss Patients
Sammi Hill, a 33-year-old mother of two from Nottingham, UK, regained her mental well-being and lost 4st (25.4kg) using Mounjaro, but a significant price increase threatens her continued access and the mental health of others.
Mounjaro Price Hike Jeopardizes Mental Health Benefits for Weight Loss Patients
Sammi Hill, a 33-year-old mother of two from Nottingham, UK, regained her mental well-being and lost 4st (25.4kg) using Mounjaro, but a significant price increase threatens her continued access and the mental health of others.
Progress
40% Bias Score
Weight Loss Jabs Curb £500-a-Month Shopping Addiction
Donique Wint, a 38-year-old civil servant from Greater Manchester, lost five stone and £500 per month in spending after starting GLP-1 medication, Mounjaro, in February 2025 to address her weight and shopping addiction.
Weight Loss Jabs Curb £500-a-Month Shopping Addiction
Donique Wint, a 38-year-old civil servant from Greater Manchester, lost five stone and £500 per month in spending after starting GLP-1 medication, Mounjaro, in February 2025 to address her weight and shopping addiction.
Progress
52% Bias Score
Novo Nordisk's Share Price Plummets Amidst Increased Competition and Market Challenges
Novo Nordisk's share price plummeted over 50 percent this year due to increased competition from Eli Lilly's Mounjaro, the prevalence of cheaper compounded GLP-1 drugs, and slower adaptation to market changes, leading to a significant loss in market value and a CEO change.
Novo Nordisk's Share Price Plummets Amidst Increased Competition and Market Challenges
Novo Nordisk's share price plummeted over 50 percent this year due to increased competition from Eli Lilly's Mounjaro, the prevalence of cheaper compounded GLP-1 drugs, and slower adaptation to market changes, leading to a significant loss in market value and a CEO change.
Progress
56% Bias Score
Limited Uptake of Anti-Obesity Drugs in France Fuels Unregulated Online Market
In France, despite expanded access to anti-obesity drugs Wegovy and Mounjaro since June 23rd, 2025, fewer than 40,000 patients were using them by late June, leading to a burgeoning but unregulated online market with varying prices (€120–€468 monthly) and safety concerns.
Limited Uptake of Anti-Obesity Drugs in France Fuels Unregulated Online Market
In France, despite expanded access to anti-obesity drugs Wegovy and Mounjaro since June 23rd, 2025, fewer than 40,000 patients were using them by late June, leading to a burgeoning but unregulated online market with varying prices (€120–€468 monthly) and safety concerns.
Progress
40% Bias Score
Failure to Conduct Blood Tests Before Prescribing Mounjaro Risks Deadly Organ Failure for Thousands
A nurse warned that thousands of NHS patients using the weight-loss jab Mounjaro are at risk of deadly organ failure because GPs are not conducting mandatory blood tests to screen for underlying health issues that could worsen the drug's side effects, including pancreatitis and severe dehydration, b...
Failure to Conduct Blood Tests Before Prescribing Mounjaro Risks Deadly Organ Failure for Thousands
A nurse warned that thousands of NHS patients using the weight-loss jab Mounjaro are at risk of deadly organ failure because GPs are not conducting mandatory blood tests to screen for underlying health issues that could worsen the drug's side effects, including pancreatitis and severe dehydration, b...
Progress
52% Bias Score
Showing 1 to 12 of 40 results